(Report ID: 66045) Drug interactions analysis of:
Divalproex Sodium, Zidovudine, Lamivudine, Azithromycin, Bactrim, SertralineMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,651 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 14 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 66045 | Mar, 8, 2006 | 30 | Male |
List of drugs the patient takes:
| Drug |
Divalproex Sodium |
Zidovudine |
Lamivudine |
Azithromycin |
Bactrim |
Sertraline |
| Name |
Drug Effect Decreased |
Drug Interaction |
Drug Level Decreased |
Mania |
Results from eHealthMe: 14 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Drug Effect Decreased | 1 (7.14%) |
Drug Interaction | 1 (7.14%) |
Drug Level Decreased | 1 (7.14%) |
Mania | 1 (7.14%) |
3) Top co-used drugs drugs reported for the past 12 months:
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Nipple Disorder | 10 (71.43%) |
2 | Facial Dysmorphism | 7 (50.00%) |
3 | Congenital Nail Disorder | 7 (50.00%) |
4 | Congenital Abnormality Nos | 6 (42.86%) |
5 | Complications Of Maternal Exposure To Therapeutic Drugs | 5 (35.71%) |
6 | Complications Of Maternal Exposure To Therapuetic Drugs | 5 (35.71%) |
7 | Congenital Limb Anomaly Nos | 5 (35.71%) |
8 | Maternal Drugs Affecting Foetus | 4 (28.57%) |
9 | Neonatal Disorder Nos | 4 (28.57%) |
10 | Congenital Foot Malformation Nos | 4 (28.57%) |
| Name | Count |
1 | Epivir | 13 |
2 | Retrovir | 13 |
3 | Combivir | 12 |
4 | Zoloft | 11 |
5 | Oxycontin | 11 |
6 | Crixivan | 11 |
7 | Zithromax | 11 |
8 | Duragesic | 11 |
9 | Zerit | 11 |
10 | Fluconazole | 9 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
